Sean Agbor-Enoh
Overview
Explore the profile of Sean Agbor-Enoh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goldberg J, deFilippi C, Lockhart C, McNair E, Sinha S, Kong H, et al.
Transplantation
. 2024 Dec;
PMID: 39630098
Background: Proteomic phenotyping can provide insights into rejection pathophysiology, novel biomarkers, and therapeutic targets. Methods: Within the prospective, multicenter Genomic Research Alliance for Transplantation study, 181 proteins were evaluated from...
2.
Goldberg J, Tian X, Bon A, Xu Y, Gerhard E, Brower R, et al.
Circ Heart Fail
. 2024 Nov;
17(12):e011592.
PMID: 39584219
Background: Heart transplant recipients with donor-specific antibodies (DSAs) have an increased risk for antibody-mediated rejection. However, many patients with graft dysfunction and DSA do not have evidence of antibody-mediated rejection...
3.
Mehta A, Goldberg J, Bagchi P, Marboe C, Shah K, Najjar S, et al.
J Heart Lung Transplant
. 2024 Oct;
PMID: 39424014
Background: There is significant variability among pathologists in the histopathological interpretation of the endomyocardial biopsy (EMB) for acute cellular rejection (ACR), and assessment of variability in the interpretation of antibody-mediated...
4.
Keller M, Tian X, Agbor-Enoh S
Am J Respir Crit Care Med
. 2024 Aug;
210(8):1066-1067.
PMID: 39167798
No abstract available.
5.
Nikolova A, Agbor-Enoh S, Bos S, Crespo-Leiro M, Ensminger S, Jimenez-Blanco M, et al.
Transpl Int
. 2024 Jul;
37:12445.
PMID: 38962472
While allograft rejection (AR) continues to threaten the success of cardiothoracic transplantation, lack of accurate and repeatable surveillance tools to diagnose AR is a major unmet need in the clinical...
6.
Keller M, Sun J, Alnababteh M, Ponor L, Shah P, Mathew J, et al.
Transplant Direct
. 2024 Jul;
10(7):e1669.
PMID: 38953039
Background: A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients. In this multicenter prospective cohort study,...
7.
Keller M, Newman D, Alnababteh M, Ponor L, Shah P, Mathew J, et al.
J Heart Lung Transplant
. 2024 May;
43(9):1374-1382.
PMID: 38705500
Background: Lung transplant recipients are traditionally monitored with pulmonary function testing (PFT) and lung biopsy to detect post-transplant complications and guide treatment. Plasma donor-derived cell free DNA (dd-cfDNA) is a...
8.
Defilippis E, Sweigart B, Khush K, Shah P, Agbor-Enoh S, Valantine H, et al.
J Heart Lung Transplant
. 2024 Mar;
43(7):1135-1141.
PMID: 38460620
Background: Noninvasive methods for surveillance of acute rejection are increasingly used in heart transplantation (HT), including donor-derived cell-free DNA (dd-cfDNA). As other cardiac biomarkers differ by sex, we hypothesized that...
9.
Goldberg J, Mehta A, Bahniwal R, Agbor-Enoh S, Shah P
Front Cardiovasc Med
. 2024 Feb;
11:1349376.
PMID: 38380175
Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of heart transplant rejection has continued to rely on histopathologic interpretation of...
10.
Shah P, Agbor-Enoh S, Lee S, Andargie T, Sinha S, Kong H, et al.
Circ Heart Fail
. 2024 Feb;
17(4):e011160.
PMID: 38375637
Background: Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. We hypothesized that this risk may be associated with higher levels of...